Form 4 for TGTX TG THERAPEUTICS, INC.
Accepted 2025-11-07 00:00:00 ET · period of report 2025-11-05 · accession 0001437749-25-033888 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-07 | 2025-11-05 | TGTX | WEISS MICHAEL S | CEO, Dir | G - Gift | $0.00 | -4.67M | 9.16M | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-05 | G | D | 3,865,126 | $0.00 | 9,959,803 | D | — | — | (F1) Represents distribution of shares upon termination of the Michael Sean Weiss 2022 Grantor Retained Annuity Trust to irrevocable trusts for the benefit of Mr. Weiss' children. (F2) Includes shares of restricted Common Stock, which vest over various time periods. |
| 2 | Common | Common Stock | 2025-11-05 | G | D | 803,717 | $0.00 | 9,156,086 | D | — | — | (F3) Represents the transfer of shares to The Weiss Family and Descendants Trust. (F2) Includes shares of restricted Common Stock, which vest over various time periods. |